Introducing BacoMind®

BacoMind® from Bacopa monnieri is a patented, clinically tested, full-spectrum extract of nine bioactive compounds to support memory and cognitive abilities for children and adults. 

BacoMind® is the only brand of Bacopa monnieri with nine different bioactives providing a holistic targeted benefit — bacopasaponin C, bacopaside I, bacopaside II, bacoside A3, beta-sitosterol-D-glucoside, jujubogenin isomer of bacopasaponin C, bacosine, apigenin and luteolin. It is also the first Bacopa to be GRAS.

BacoMind®: 9 unique bioactives

Traditional uses

Bacopa monnieri has been relied upon in India by Ayurvedic medical practitioners for nearly 3,000 years. Ayurvedic practitioners have classified Bacopa as a ‘medhyarasayana’, a treatment for improving memory and intellect (‘medhya’). Additionally, the herb has been mentioned in several ancient Ayurvedic treatises including the Charaka Samhita (6th century AD) and, about 1,000 years later, the Bravprakash Var-Prakarana (16th century AD).

As Brahmi, Bacopa has been utilized in traditional Ayurveda as a nerve tonic to improve learning, memory, and concentration, as well as to relieve anxiety and support against epileptic disorders.

Brahmi is said to balance both brain hemispheres as well as to stimulate awakening of the crown chakra Sahastrara, the seventh spiritual chakra at the top of the head.

BacoMind® clinical research

BacoMind® is clinically researched to support cognitive performance with four human efficacy clinical trials — two in elderly populations, two in children, and one safety human study.

Clinical Study 1

BacoMind® improved memory acquisition and retention

Clinical Study 2

BacoMind® improved verbal memory

Clinical Study 3

Children requiring IEP showed improvement in the battery of memory tests.

Clinical Study 4

BacoMind® significantly (p<0.05) reduced 6 out of 7 symptoms of ADHD in all children

Clinical Study 5

BacoMind® was found to be safe for human consumption

A randomized double blind placebo controlled study in elderly Australians for memory

Condition

Healthy elderly individuals

Dose

300 mg per day

Participants

98 elderly individuals (Age: ≥55 years)

Duration

12 weeks

Evaluation

At 12 weeks

Outcome

BacoMind® improved memory acquisition and retention

Morgan and Stevens.The Journal of Alternative and Complimentary Medicine 2010, 16 : 753-759

Know More

Effect of BacoMind® in elderlies

A randomized double blind placebo-controlled study in elderly Indians for memory

Condition

Healthy elderly individuals

Dose

450 mg per day after breakfast

Participants

65 elderly individuals (Age: 50-75 years)

Duration

12 weeks

Evaluation

At 12 weeks and at 24 weeks (BacoMind® administered for 12 weeks only)

Outcome

BacoMind® improved verbal memory

Barbhaiya et al. Journal of Pharmacology and Toxicology 2008, 3: 425-434

Know More

Effect of BacoMind® in elderlies

An open labeled clinical study in children requiring IEP

Condition

Children requiring Individual Education Program (IEP)

Dose

225 mg per day

Participants

24 children (Age: 4-18 years)

Duration

4 months

Evaluation

At 4 months

Outcome

Children requiring IEP showed improvement in the battery of memory tests

Usha et al. Journal of Pharmacology and Toxicology 2008, 3(4): 302-310

Know More

Effects of BacoMind® in children requiring IEP

Open labeled study in children with ADHD

Condition

ADHD (Attention Deficit Hyperactivity Disorder)

Dose

225 mg per day

Participants

27 children (Age: 6-12 years)

Duration

6 months

Evaluation

At 6 months

Outcome

BacoMind® significantly (p<0.05) reduced 6 out of 7 symptoms of ADHD in all children

Dave et al. Advances in Mind-Body Medicine 2014, 28(2):10-5

Know More

Effects of BacoMind® in children with ADHD

A randomized, open label, dose escalation safety study in healthy adults

Condition

Healthy adults

Dose

300 mg per day for 15 days continued with 450 mg per day for next 15 days

Participants

23 elderly individuals (Age: 18-45 years)

Duration

30 days

Evaluation

Pre and post treatment

Outcome

BacoMind® was found to be safe for human consumption

Bacomind® pre-clinical research

Preliminary research in rats and mice have demonstrated that both an aqueous decoction and alcoholic extract enhanced learning ability in rats, as well as facilitated cognitive function and mental retention capacity.

These studies informed the objective of a pre-clinical study evaluating the nootropic activity of BacoMind® in different learning and memory paradigms such as elevated plus maze, passive shock avoidance test, and object recognition test. BacoMind® was administered for 7 days to mice in an elevated plus maze and passive shock avoidance test, and to rats in object recognition test. Scopolamine was used to induce forgetfulness (amnesia) and piracetam served as a reference standard.

Results were highly encouraging, demonstrating that BacoMind® has strong nootropic activity. In the elevated plus maze test, BacoMind® significantly increased the inflexion ratio in scopolamine treated mice. In passive shock avoidance test, BacoMind® significantly reduced the latency to reach the shock free zone and number of mistakes in 15 minutes in both normal as well as scopolamine treated mice. In object recognition test, BacoMind® significantly increased the discrimination index in both normal as well as scopolamine treated rats.

Reference: Kasture et al.. Journal of Natural Remedies 2007, 7(1): 166-173

BacoMind®: Unique mechanism of action

BacoMind®– Only Bacopa with human safety study

The subjective and objective evaluation of BacoMind® in healthy adult volunteers revealed that, at the given oral dose of 300 mg once a day for first 15 days and 450 mg once a day for next 15 days, the herbal supplement was found to be safe and tolerable.

Dosage*

Adults: 300 to 450 mg per day

Children: 225 mg per day

Health Benefits

BacoMind®– Only Bacopa extract with GRAS

The first brand of Bacopa extract to receive GRAS status — can be used as a food ingredient in beverages, candies (including gummies, chews, etc), and bakery products (including protein and breakfast bars) at levels of 50 mg per serving.

BacoMind®: Stands for the things that matter to you

BacoMind®: Sustainably making a difference at every step

The process of cultivating Bacopa monnieri for BacoMind® has always been one that keeps renewability of resources – including human – at the forefront to sustain quality yields. We minimize our carbon footprint by cultivating mostly with non-fossil fuels and without machinery that uses the fossil fuels. We reuse the water used for growing the botanical crop. During manufacturing/processing, most of the power utilized is from hydro and solar energy sources. All the effluents from the manufacturing facility are disposed responsibly as per statutory norms. We are an ISO14001-certified (environmental management) organization, and our manufacturing facility is surrounded by trees to provide a green belt.

Further, for today’s consumer whose standards are higher than ever – requiring that the companies they support are those that support the earth and ensure safety and transparency, BacoMind® is attractive. Consumers will appreciate its clean label attributes – USP compliant for pesticide residue and heavy metals, non-irradiated, NON-GMO Project-verified, and is certified both Kosher and Halal.

BacoMind® is manufactured under strict global guidelines of safety and quality control. Its manufacturer, Natural Remedies, has achieved ISO 22000, ISO 9001and OHSAS 18001 certification from Bureau Veritas, is NSF GMP-certified, USFDA inspected.

Why choose BacoMind®?

World’s best Bacopa

Learn More

*Disclaimer:This website may contain statements and classification about product(s), which may not be in line with the regulations of your country. The statement or claims made are in reference to the ingredient only and therefore do not refer to any finished product directly or indirectly. The claims on the finished product containing our ingredient are the sole responsibility of manufacturer or the marketer. We urge manufacturer and marketer to ensure that the claims made on the finished product comply with the law and regulation of the country in which the product is to be sold. Statements used in this website have not been evaluated by FDA. The ingredient mentioned here is not intended to diagnose, treat, cure or prevent any disease.